Rapport Therapeutics Stock (NASDAQ:RAPP)

Ownership Financials Chart

Previous Close

$9.51

52W Range

$6.43 - $29.74

50D Avg

$10.11

200D Avg

$16.65

Market Cap

$310.59M

Avg Vol (3M)

$229.27K

Beta

0.11

Div Yield

-

RAPP Company Profile

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

69

IPO Date

-

Website

RAPP Performance

RAPP Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-83.06M	$-36.18M	$-10.37M
Net Income	$-78.31M	$-34.79M	$-10.65M
EBITDA	$-83.06M	$-34.66M	$-10.35M
Basic EPS	$-0.38	$-0.21	$-0.29
Diluted EPS	$-0.38	$-0.21	$-0.29

Fiscal year ends in Dec 24 | Currency in USD